Reporting Manager
TANG CAPITAL MANAGEMENT, LLC
Symbol
TARS
Shares outstanding
41,606,729 shares
Disclosed Ownership
2,454,797 shares
Ownership
5.9%
Form type
SCHEDULE 13G/A
Filing time
15 May 2025, 16:15:23 UTC
Date of event
31 Mar 2025
Next filing
17 Feb 2026

Sponsored

Quoteable Key Fact

"TANG CAPITAL MANAGEMENT LLC disclosed 5.9% ownership in Tarsus Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (TARS) on 31 Mar 2025."

Quick Takeaways

  • TANG CAPITAL MANAGEMENT LLC filed SCHEDULE 13G/A for Tarsus Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (TARS).
  • Disclosed ownership: 5.9%.
  • Date of event: 31 Mar 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 15 May 2025, 16:15.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (6)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
TANG CAPITAL MANAGEMENT, LLC 5.9% 2,454,797 0 2,454,797 /s/ Kevin Tang Manager
KEVIN TANG 5.9% 2,454,797 0 2,454,797 /s/ Kevin Tang Self
TANG CAPITAL PARTNERS, LP 5.6% 2,334,439 0 2,334,439 /s/ Kevin Tang Manager, Tang Capital Management, LLC, General Partner
TANG CAPITAL PARTNERS INTERNATIONAL, LP 0.15% 62,358 0 62,358 /s/ Kevin Tang Manager, Tang Capital Management, LLC, General Partner
TANG CAPITAL PARTNERS III, INC 0.1% 43,500 0 43,500 /s/ Kevin Tang Chief Executive Officer
TANG CAPITAL PARTNERS IV, INC 0.04% 14,500 0 14,500 /s/ Kevin Tang Chief Executive Officer